Rankings
▼
Calendar
RXRX Q3 2020 Earnings — Recursion Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RXRX
Recursion Pharmaceuticals, Inc.
$2B
Q3 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$862,000
Gross Profit
$862,000
100.0% margin
Operating Income
-$22M
-2607.2% margin
Net Income
-$24M
-2769.5% margin
EPS (Diluted)
$-0.14
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$20M
Stock-Based Comp.
$1M
← FY 2020
All Quarters
Q4 2020 →
